Pharnext to Present at 7th Annual CEC Capital Summit

Date : 09/13/2017 @ 10:45AM
Source : Business Wire
Stock : Pharnext (ALPHA)
Quote : 8.0  0.1 (1.27%) @ 7:01AM
Pharnext share price Chart

Pharnext to Present at 7th Annual CEC Capital Summit

Pharnext (EU:ALPHA)
Historical Stock Chart

1 Year : From Jun 2017 to Jun 2018

Click Here for more Pharnext Charts.

Regulatory News:

Pharnext SA (Paris:ALPHA) (FR00111911287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced that company management will present a corporate overview at the 7th Annual CEC Capital Summit.

The presentation will take place as follows:

  • Date: Wednesday, September 20th, 2017
  • Time: 2:50 pm PDT (11:50 pm CEST)
  • Venue: Montage Beverly Hills in Beverly Hills, California

If you are interested in meeting the Pharnext management team during this event, please send an email to Matthew Shinseki at

About PharnextPharnext is an advanced clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the United States. PXT864 has generated positive Phase 2 results in Alzheimer’s disease. Pharnext is the pioneer of a new drug discovery paradigm: PLEOTHERAPY™. The Company identifies and develops synergic combinations of repositioned drugs at new optimal lower doses. These PLEODRUG™ offer several key advantages: efficacy, safety and intellectual property including several product or composition of matter patents already granted. The Company is supported by a world-class scientific team.

The company Pharnext is listed on Euronext Growth Stock Exchange in Paris (ISIN code: FR00111911287).For more information, visit

PharnextXavier Paoli, +33 (0)1 41 09 22 30Chief Commercial Officercontact@pharnext.comorInvestor Relations (Europe)MC Services AGAnne Hennecke, +49 211 529252 22anne.hennecke@mc-services.euorMedia Relations (Europe)ALIZE RPCaroline CarmagnolMargaux Pronost+33 (0)1 44 54 36 64pharnext@alizerp.comorInvestor Relations (U.S.)Stern Investor Relations, Inc.Matthew Shinseki, +1 212-362-1200matthew@sternir.comorMedia Relations (U.S.)Russo PartnersTony RussoScott 212-845-4251+1 718-344-5843orFinancial Communication (France)New CAPEmmanuel Huynh, +33 (0)1 44 71 20

Your Recent History
Ivanhoe Mi..
Canadian D..
Xumanii In..
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:ca D:20180625 13:50:10